Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 2,293 shares at $3.38 ($8K) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Seasonal sale ($8k) by CEO — this insider has traded RCKT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCKT | SELL | 2026-05-21 | $7K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |
| RCKT | SELL | 2026-02-20 | $20K | — | Filing → |